Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Diabetes|April 30, 2003
A new murine model of islet xenograft rejection: graft destruction is dependent on a major histocompatibility-specific interaction between T-cells and macrophagesPeter Schmidt, Henrik Krook, Akira Maeda, et al.
Cell Transplantation|January 10, 2003
Co-stimulatory molecules in islet xenotransplantation: CTLA4Ig treatment in CD40 ligand-deficient miceBirgitta Benda, Hans-Gustaf Ljunggren, Robert Peach, et al.
Annals of the Rheumatic Diseases|March 17, 2023
Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL SurveillanceLars Erik Kristensen, Silvio Danese, Arne Yndestad, et al.
Annals of the Rheumatic Diseases|April 24, 2015
Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programmeJeffrey R Curtis, Eun Bong Lee, Irina V Kaplan, et al.
The Journal of Rheumatology|November 16, 2021
Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based StudyJeffrey R Curtis, Xiaofeng Zhou, David T Rubin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2014
Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritisStanley Cohen, Sebastião C Radominski, Juan J Gomez-Reino, et al.
Lancet (London, England)|January 9, 2013
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trialGerd R Burmester, Ricardo Blanco, Christina Charles-Schoeman, et al.
The Journal of Rheumatology|April 3, 2014
Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, for the treatment of rheumatoid arthritis in open-label, longterm extension studiesJürgen Wollenhaupt, Joel Silverfield, Eun Bong Lee, et al.
Arthritis and Rheumatism|January 26, 2013
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic studyDésirée van der Heijde, Yoshiya Tanaka, Roy Fleischmann, et al.
Pageof 1